| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918414 | Radiotherapy and Oncology | 2014 | 5 Pages |
Abstract
The addition of nitroglycerin to induction chemotherapy and concurrent chemoradiotherapy in patients with locally advanced NSCLC has an acceptable toxicity profile and supports the possibility to add nitroglycerin to chemotherapy and radiotherapy. A randomized trial is warranted to confirm these findings.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Oscar Arrieta, Mónika Blake, MarÃa Dolores de la Mata-Moya, Francisco Corona, Jenny Turcott, David Orta, Jorge Alexander-Alatorre, Dolores Gallardo-Rincón,